Diamonds and Dogs


Eli Lilly (LLY) soaring today. The drug maker is up 7% after the FDA granted breakthrough therapy designation to Lilly's experimental Alzheimer's disease drug donanemab. Lilly also said that it plans to file for accelerated FDA approval of the drug later this year. The drug could produce billions in sales in the coming years if approved. A number of upgrades with price targets as high as $300 a share.

Profit-taking in KB Homes (KBH). The homebuilder is down 6% following earnings. Earnings easily beat expectations as revenue rose 57% to $1.44 billion but missed expectations. KB Home does have a backlog of homes to build worth $4 billion. I hope they bought the lumber already.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.